About Onconetix Inc
Ticker
info
ONCO
Trading on
info
NASDAQ
ISIN
info
US68237Q1040
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Karina M. Fedasz
Headquarters
info
201 East Fifth Street, Cincinnati, OH, United States, 45202
Employees
info
5
Website
info
onconetix.com
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
Metrics
BasicAdvanced
Market cap
info
$4.6M
P/E ratio
info
0
EPS
info
$1,229.73
Dividend Yield
info
0.00%
Beta
info
3.42
Forward P/E ratio
info
0
EBIDTA
info
$-4.7M
Ex dividend date
info
-
Price & volume
Market cap
info
$4.6M
Average daily volume
info
0M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
3.8
Price to book
info
1.38
Earnings
EPS
info
$1,229.73
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-4.7M
Revenues (TTM)
info
$1.2M
Revenues per share (TTM)
info
$2.14
Technicals
Beta
info
3.42
52-week High
info
$79.05
52-week Low
info
$2.10
50-day moving average
info
$3.07
200-day moving average
info
$6.38
Short ratio
info
2.24
Short %
info
4.15%
Management effectiveness
ROE (TTM)
info
-221.37%
ROA (TTM)
info
-7.41%
Profit margin
info
0.00%
Gross profit margin
info
$1M
Operating margin
info
-681.45%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
-25.40%
Share stats
Outstanding Shares
info
1.6M
Float
info
1.3M
Insiders %
info
19.54%
Institutions %
info
6.26%
Analyst Insights & forecasts
info

0% Buy

100% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$9.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$2.93
-
-
Q4 • 24Beat
-$45.44
-
-
Q1 • 25Beat
-$4.18
-
-
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0.1M
$-2.4M
-2,227.77%
Q2 • 25
$0.3M
$-8.8M
-2,892.70%
Q3 • 25
185.13%
270.24%
29.85%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$19.1M
$13.2M
69.09%
Q2 • 25
$19.7M
$16.3M
82.85%
Q3 • 25
2.93%
23.42%
19.91%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-1.4M
$0M
$0.7M
$-1.4M
Q2 • 25
$-3.2M
$0M
$4.3M
$-3.2M
Q3 • 25
125.33%
-
476.32%
125.33%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Onconetix Inc share?
Collapse

Onconetix Inc shares are currently traded for undefined per share.

How many shares does Onconetix Inc have?
Collapse

Onconetix Inc currently has 1.6M shares.

Does Onconetix Inc pay dividends?
Collapse

No, Onconetix Inc doesn't pay dividends.

What is Onconetix Inc 52 week high?
Collapse

Onconetix Inc 52 week high is $79.05.

What is Onconetix Inc 52 week low?
Collapse

Onconetix Inc 52 week low is $2.10.

What is the 200-day moving average of Onconetix Inc?
Collapse

Onconetix Inc 200-day moving average is $6.38.

Who is Onconetix Inc CEO?
Collapse

The CEO of Onconetix Inc is Karina M. Fedasz.

How many employees Onconetix Inc has?
Collapse

Onconetix Inc has 5 employees.

What is the market cap of Onconetix Inc?
Collapse

The market cap of Onconetix Inc is $4.6M.

What is the P/E of Onconetix Inc?
Collapse

The current P/E of Onconetix Inc is 0.

What is the EPS of Onconetix Inc?
Collapse

The EPS of Onconetix Inc is $1,229.73.

What is the PEG Ratio of Onconetix Inc?
Collapse

The PEG Ratio of Onconetix Inc is null.

What do analysts say about Onconetix Inc?
Collapse

According to the analysts Onconetix Inc is considered a hold.